Versant Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329K | Buy |
28,419
+16,337
| +135% | +$189K | 0.05% | 295 |
|
|
2025
Q1 | $105K | Buy |
12,082
+11,800
| +4,184% | +$103K | 0.02% | 608 |
|
|
2024
Q4 | $4.05K | Sell |
282
-1,323
| -82% | -$19K | ﹤0.01% | 1858 |
|
|
2024
Q3 | $36.2K | Buy |
1,605
+1,400
| +683% | +$31.6K | 0.01% | 561 |
|
|
2024
Q2 | $3.99K | Buy |
+205
| New | +$3.99K | ﹤0.01% | 1292 |
|
|
2022
Q1 | – | Sell |
-2
| Closed | – | – | 1632 |
|
|
2021
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1590 |
|